W. Michael Kavanaugh
2015
In 2015, W. Michael Kavanaugh earned a total compensation of $2.4M as Chief Scientific Officer and Head of Research and Non- Clinical Development at CytomX Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $197,507 |
|---|---|
| Option Awards | $1,864,560 |
| Salary | $348,253 |
| Other | $2,532 |
| Total | $2,412,852 |
Kavanaugh received $1.9M in option awards, accounting for 77% of the total pay in 2015.
Kavanaugh also received $197.5K in non-equity incentive plan, $348.3K in salary and $2.5K in other compensation.
Rankings
In 2015, W. Michael Kavanaugh's compensation ranked 3,980th out of 13,638 executives tracked by ExecPay. In other words, Kavanaugh earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,980 out of 13,638 | 71st |
Division Manufacturing | 1,450 out of 5,190 | 72nd |
Major group Chemicals And Allied Products | 527 out of 1,854 | 72nd |
Industry group Drugs | 418 out of 1,528 | 73rd |
Industry Pharmaceutical Preparations | 330 out of 1,182 | 72nd |
Source: SEC filing on May 9, 2017.
Kavanaugh's colleagues
We found three more compensation records of executives who worked with W. Michael Kavanaugh at CytomX Therapeutics in 2015.